Are you looking for concise, practical answers to those questions that are often left unanswered by traditional references of the retina? Are you seeking brief, evidence-based advice for the daily examination of patients? Curbside Consultation in Retina: 49 Clinical Questions
provides quick and direct answers to questions most commonly posed during a “curbside consultation” between experienced clinicians.
Dr. Sharon Fekrat, along with associate editors Drs. Darius Moshfeghi and Dean Eliott, have designed this unique reference that offers expert advice, preferences, and opinions on a variety of clinical questions commonly associated with the retina. The unique Q&A format provides quick access to current information related to the retina with the simplicity of a conversation between two colleagues. Images and references are included to enhance the text and to illustrate clinical diagnoses.
Curbside Consultation in Retina: 49 Clinical Questions provides information basic enough for residents while also incorporating expert pearls that even high-volume ophthalmologists and specialists will appreciate. Optometrists, ophthalmologists, ophthalmologists-in-training, and even retina specialists will benefit from the user-friendly and casual format and the expert advice contained within.
Some of the questions that are answered:
• What is the treatment paradigm for postop CME?
• How do I follow a patient who is pregnant and also has diabetes?
• How should I counsel my patients with dry AMD and what-about various vitamin supplements?
• What systemic medications require periodic fundus evaluation, what do I look for and what tests do I do?
• How can I differentiate all of those white dot syndromes?
Sharon Fekrat, MD, FACS
joined the Vitreoretinal Surgical Service at the Duke Eye Center in 1998 after completing her ophthalmology and vitreoretinal training at the Wilmer Eye Institute of the Johns Hopkins Medical Institutions. She is now a tenured associate professor of ophthalmology at Duke and the Chief of Ophthalmology at the Durham Veterans Affairs Medical Center. She has co-authored over 60 peer-reviewed articles and over 30 book chapters, is on the editorial board of four professional journals, and has served as site principal investigator for numerous multicenter clinical trials. She is co-editor of Duke Eye Center’s All About Your Eyes
book for the lay public. Dr. Fekrat is past president of the North Carolina Society of Eye Physicians and Surgeons.
Darius Moshfeghi, MD joined Stanford University in 2002 after completing fellowships in vitreoretinal surgery at the Cole Eye Institute of the Cleveland Clinic and in ocular oncology at the University of Tennessee Memphis and St. Jude Children’s Research Hospital. He is an associate professor of ophthalmology where he leads the pediatric vitreoretinal surgery service and is Co-Director of the ocular oncology service. He is the Founder and Director of the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) telemedicine outreach initiative, the largest telemedicine network for ROP in the United States. He has co-authored over 70 peer-reviewed, indexed journal articles and 20 book chapters, and serves on the editorial board of a professional journal. He is the Director of the Vitreoretinal Surgery Fellowship program at Stanford University.
Dean Eliott, MD is Director of the Doheny Retina Institute and Professor of Ophthalmology at the Doheny Eye Institute and Keck School of Medicine, University of Southern California in Los Angeles, CA. Dr. Eliott completed his residency at the Wilmer Eye Institute, Johns Hopkins Hospital, in Baltimore, MD, and he received his vitreoretinal fellowship training at the Duke Eye Center, Duke University Medical Center, in Durham, NC. He then served as Chief Resident and vitreoretinal faculty member at the Duke Eye Center. Before joining the Doheny Eye Institute, Dr. Eliott was Director of the Retina Service at the Kresge Eye Institute of Wayne State University in Detroit, MI. Dr. Eliott has served as principal investigator for many clinical trials, and he has numerous publications in ophthalmic journals and textbooks.
About the Editors
Foreword by Dr. Julia A. Haller, MD
Question 1: What Are Some Tips to Differentiate Visual Loss From Retinal Disease Versus Cataract?
Craig M. Greven, MD
Question 2: What Retinal Findings Would Require Treatment Prior to Cataract or Refractive Surgery?
Steven Bailey, MD
Question 3: What Should I Tell a Myope About the Risk of Retinal Detachment After Cataract or Refractive Surgery?
Franco M. Recchia, MD
Question 4: How Do I Manage Lattice Degeneration?
Suber S. Huang, MD, MBA
Question 5: What Retinal Breaks Require Treatment and How Are They Treated?
Ron Afshari Adelman, MD, MPH
Question 6: What Lesions in the Fellow Eye of a Patient With a Retinal Break or Detachment Require Treatment?
Steven Sanislo, MD
Question 7: How Soon Should a Patient With Floaters Be Examined and How Should I Manage a Patient With an Acute Posterior Vitreous Detachment?
Karen M. Gehrs, MD
Question 8: How Long Should I Wait to Perform Cataract Surgery After Treatment of Diabetic Macular Edema or Retinopathy?
Linda A. Lam, MD
Question 9: Does Cataract Surgery in an Eye With Dry Age-Related Macular Degeneration Increase the Risk of Developing Choroidal Neovascularization?
Andrew A. Moshfeghi, MD
Question 10: What Should I Do When I See a Patient With a Hollenhorst Plaque?
Anita Agarwal, MD
Question 11: What Should I Do When I See a Patient With One or More Cotton-Wool Spots?
Jorge G. Arroyo, MD, MPH
Question 12: What Should I Do When I See a Patient With One or More Intraretinal Hemorrhages?
Christopher N. Singh, MD
Question 13: How Do I Work-Up and Manage a Patient With a Vitreous Hemorrhage?
Pauline T. Merrill, MD
Question 14: How Can Optical Coherence Tomography Help Me in My Practice and What Can It Detect?
Elias Reichel, MD
Question 15: With the Rapidly Advancing Technology of Optical Coherence Tomography, Is There Still a Role for Fluorescein Angiography?
Asheesh Tewari, MD
Question 16: How Important Is a Prompt Diagnosis of Macular Hole?
William E. Smiddy, MD
Question 17: When Should I Refer a Patient With an Epiretinal Membrane and What if There Is Associated Cystoid Macular Edema?
Gaurav K. Shah, MD
Question 18: How Do I Differentiate a Macular Hole From a Lamellar Hole, an Epiretinal Membrane With a Pseudohole, Cystoid Macular Edema, and Vitreomacular Traction, and Why Do I Care?
SriniVas R. Sadda, MD
Question 19: How Should a Patient With a Gas Bubble Position His or Her Head and What Precautions Should He or She Follow?
Abdhish R. Bhavsar, MD
Question 20: What Is Central Serous Retinopathy and How Do I Treat It?
Jennifer I. Lim, MD
Question 21: What Is the Treatment Paradigm for Postoperative Cystoid Macular Edema?
Rishi P. Singh, MD
Question 22: Which Patients With Unilateral or Bilateral Dry Age-Related Macular Degeneration Are at Highest Risk for Developing Wet Age-Related Macular Degeneration?
Karl G. Csaky, MD, PhD
Question 23: How Do I Counsel My Patients With Dry Age-Related Macular Degeneration and What About Various Vitamin Supplements?
Catherine B. Meyerle, MD
Question 24: What Drugs Can Be Injected Intravitreally and What Ocular and Systemic Complications Should I Look Out For?
Diana V. Do, MD
Question 25: Why Are There so Many Different Triamcinolone Preparations and Which One Should I Use?
Sophie J. Bakri, MD
Question 26: How Do I Monitor for Steroid-Induced Glaucoma After an Intravitreal Injection?
Baruch D. Kuppermann, MD, PhD
Question 27: What Systemic Medications Require Periodic Fundus Evaluation, What Am I Looking For, and What Tests Do I Do?
William F. Mieler, MD
Question 28: How Should I Follow Diabetic Macular Edema and When Does It Require Treatment?
Peter K. Kaiser, MD
Question 29: When Should Eyes With Proliferative Diabetic Retinopathy Receive Panretinal Laser Photocoagulation?
Ivan J. Suñer, MD
Question 30: When Should I Refer a Patient With Diabetic Retinopathy for a Vitrectomy?
Ronald C. Gentile, MD
Question 31: How Do I Follow a Patient Who Has Diabetes and Becomes Pregnant? What Tests Can I Do?
Judy E. Kim, MD
Question 32: When Do I Refer a Patient With a Branch Retinal Artery Occlusion or Central Retinal Artery Occlusion, What Is the Work-Up, and What Are the Treatment Options?
Todd Klesert, MD, PhD
Question 33: What Do I Do When I See Someone With a Branch Retinal Vein Occlusion and What Are the Treatment Options?
Michael S. Ip, MD
Question 34 : When Do I Refer a Patient With a Central Retinal Vein Occlusion, What Is the Work-Up, and What Are the Treatment Options?
Richard Spaide, MD
Question 35: If I See a Patient With Shaken Baby Syndrome, What Are the Next Steps?
Christine R. Gonzales, MD
Question 36: What Type of Intraocular Lens Should Be Considered in an Eye With Vitreoretinal Disease?
Kourous A. Rezaei, MD
Question 37: When a Posterior Capsular Tear Occurs During Cataract Surgery, What Next?
Timothy W. Olsen, MD
Question 38: When Should a Patient With Dropped Cataract Material or Dislocated Intraocular Lens Be Referred to a Retinal Specialist?
Steven D. Schwartz, MD
Question 39: How Do I Manage a Suprachoroidal Hemorrhage?
Odette M. Houghton, MD
Question 40: When Should I Suspect Endophthalmitis in My Postoperative Cataract Patient and What Are the Treatment Options?
Bernard H. Doft, MD
Question 41: How Do I Follow a Patient With a Presumed Choroidal Nevus?
Prithvi Mruthyunjaya, MD
Question 42: How Do I Distinguish One Pigmented Lesion From Another?
Amy C. Schefler, MD
Question 43: How Do I Know if There Is a Retinal Detachment or Tumor When I Am Doing Ultrasonography?
Cathy DiBernardo, CDOS, ROUB and James T. Handa, MD
Question 44: After a Closed Globe Injury, What Vitreoretinal Findings Should I Expect and When Do I Refer?
Esther M. Bowie, MD
Question 45: What Should I Tell a Patient With Retinitis Pigmentosa About His or Her Prognosis and Should I Prescribe Vitamin Supplements?
Raymond Iezzi, MD, MS
Question 46: Which Patients Should I Refer for Electrophysiology Testing and What Might the Test Show?
Amani A. Fawzi, MD
Question 47: How Do I Differentiate All of Those White Dot Syndromes?
Sunil K. Srivastava, MD
Question 48: How Do I Work Up a Patient With Intermediate Uveitis or Panuveitis?
Thomas A. Albini, MD
Question 49 : How Do I Differentiate the Infectious Posterior Uveitides And What Are the Current Treatments?
JP Dunn, MD